Literature DB >> 1764868

Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective.

R M Fielding1.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1764868     DOI: 10.2165/00003088-199121030-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  45 in total

1.  Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteers.

Authors:  S W Sanders; K N Buchi; M S Goddard; J K Lang; K G Tolman
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

2.  Liposomes with entrapped doxorubicin exhibit extended blood residence times.

Authors:  M B Bally; R Nayar; D Masin; M J Hope; P R Cullis; L D Mayer
Journal:  Biochim Biophys Acta       Date:  1990-03-30

3.  Neutrophil-mediated transport of liposomes across the Madin Darby canine kidney epithelial cell monolayer.

Authors:  M J Cho; J F Scieszka; C T Cramer; D P Thompson; T J Vidmar
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

Review 4.  Physiology and physiopathology of the reticuloendothelial system.

Authors:  T M Saba
Journal:  Arch Intern Med       Date:  1970-12

Review 5.  Liposomes: preparation, characterization, and preservation.

Authors:  D Lichtenberg; Y Barenholz
Journal:  Methods Biochem Anal       Date:  1988

6.  Reversible depression of the reticuloendothelial system by liposomes.

Authors:  H Ellens; E Mayhew; Y M Rustum
Journal:  Biochim Biophys Acta       Date:  1982-02-25

7.  Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies.

Authors:  A Gabizon; D C Price; J Huberty; R S Bresalier; D Papahadjopoulos
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

8.  Interactions of liposomes with serum proteins.

Authors:  F Bonté; R L Juliano
Journal:  Chem Phys Lipids       Date:  1986 Jun-Jul       Impact factor: 3.329

9.  Distribution and metabolism of lipsome-encapsulated and free 1-beta-D-arabinofuranosylcytosine (Ara-C) in dog and mouse tissues.

Authors:  H Ellens; Y Rustum; E Mayhew; E Ledesma
Journal:  J Pharmacol Exp Ther       Date:  1982-08       Impact factor: 4.030

10.  Liposomal amphotericin-B in the control of experimental aspergillosis in mice: Part I--Relative therapeutic efficacy of free and liposomal amphotericin-B.

Authors:  I Ahmad; A K Sarkar; B K Bachhawat
Journal:  Indian J Biochem Biophys       Date:  1989-12       Impact factor: 1.918

View more
  20 in total

1.  Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats.

Authors:  G W Boswell; I Bekersky; D Buell; R Hiles; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

2.  Antiangiogenic activity of sterically stabilized liposomes containing paclitaxel (SSL-PTX): in vitro and in vivo.

Authors:  Yue Huang; Xiao-Mei Chen; Bing-Xiang Zhao; Xi-Yu Ke; Bo-Jun Zhao; Xin Zhao; Ying Wang; Xuan Zhang; Qiang Zhang
Journal:  AAPS PharmSciTech       Date:  2010-05-05       Impact factor: 3.246

Review 3.  Carrier erythrocytes. Clinical pharmacokinetic considerations.

Authors:  M Tonetti; A De Flora
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

Review 4.  Newer antifungal agents.

Authors:  Walid Abuhammour; Eyassu Habte-Gaber
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

Review 5.  Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.

Authors:  G Gregoriadis; A T Florence
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

6.  Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages.

Authors:  C O Onyeji; C H Nightingale; D P Nicolau; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

7.  Enhancement of tissue delivery and receptor occupancy of methylprednisolone in rats by a liposomal formulation.

Authors:  E V Mishina; R M Straubinger; N A Pyszczynski; W J Jusko
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

8.  Fractal aggregates induced by liposome-liposome interaction in the presence of Ca2+.

Authors:  J Sabín; G Prieto; J M Ruso; F Sarmiento
Journal:  Eur Phys J E Soft Matter       Date:  2007-11-14       Impact factor: 1.890

Review 9.  Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

Authors:  S Kim
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Novel taxol formulations: preparation and characterization of taxol-containing liposomes.

Authors:  A Sharma; R M Straubinger
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.